NIH

Category

NIH Launches Massive Initiative for COVID-19 Patient Data Analytics

As the COVID-19 pandemic begins to rear its head again in the wake of reopenings in the U.S., accelerating the research pipeline for treatments and vaccines becomes more important than ever. Now, the National Institutes of Health (NIH) is launching a massive COVID-19...

UC San Diego’s ACTRI Driving Results, $55m of New Funding & an Exciting Future for 8th Largest U.S. City

The Altman Clinical and Translational Research Institute (ACTRI) at University of California San Diego received a five-year, $54.7 million Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Science (NCATS), part of the...

Kaiser Permanente Washington Health Research Institute Doses First Patient for COVID-19 Vaccine with Moderna’s mRNA-1273

A Phase I clinical trial evaluating Moderna’s mRNA-1273 to fight against COVID-19 commenced at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle—the clinical investigational site was able to dose the first patient. The National Institute of...

NIAID Recent Advances in Addressing TB

A new “Perspective” in the Journal of Infectious Diseases by NIAID Director Anthony S. Fauci, MD, and other institute officials summarizes recent progress in improved TB diagnostics, therapeutic regimens and prevention approaches that made 2019 a “banner year” for TB...

Pin It on Pinterest